Huntsman Cancer Institute joins with other institutions through myeloMATCH, a program that matches patients with clinical trials that specifically target their disease.
Huntsman Cancer Institute researchers have identified a gene variant found in a high-altitude Andean population that may predict severity of diseases and responses to treatments for patients with certain types...
Inspired by their father's battle with non-Hodgkin lymphoma, Adalyn Wood and her sisters have generated over $10,000 for cancer research with their Cookies for the Cure stand.
Landmark survey illustrates the care barriers that rural and frontier communities face throughout the Mountain West. This groundbreaking work helps Huntsman Cancer Institute address these disparities more effectively.
Huntsman Cancer Institute and the Price College of Engineering have selected six teams to receive collaborative grants for a new program that aims to find solutions for cancer problems.
A young professional's life changes with a Hodgkin lymphoma diagnosis, leading to a challenging period of treatment, self-discovery, and ultimately finding purpose as a patient advocate.
State Senator Denise Hayman, dedicated advocate for the people of Montana, is being treated for a rare cancer. A clinical trial at Huntsman Cancer Institute has provided her with hope.
Experts at Huntsman Cancer Institute answer frequently asked questions about multiple myeloma, including how the disease works and what treatment options are available.
Results from mouse models presented at the prestigious American Society of Hematology show that nutrients consumed by an expectant mother during pregnancy can shape their offspring’s blood systems.
An associate professor in the division of hematology and hematopoietic malignancies, Buckley has been tapped to lead a program focused on cancer biology and how healthy cells transform into cancer.
Read about cutting-edge cancer research centered around elephant genes, a new clinical trial, and grants to study vaccination hesitance in the Mountain West as well as chronic lymphocytic leukemia.
Many dry shampoo brands are under voluntary recall after the FDA found many contained a carcinogen called benzene. Learn more about benzene, why it’s harmful, and your risk of exposure.
Read how researchers discovered genetic markers that hinder pancreatic cancer treatment and mutations that increase sarcoma risk. Then learn how artificial intelligence is helping predict prostate cancer outcomes and see...
